1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
------------------
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 1) 1
T CELL SCIENCES, INC.
- --------------------------------------------------------------------------------
(Name of issuer)
COMMON SHARES, PAR VALUE $.001
- --------------------------------------------------------------------------------
(Title of class of securities)
872342 10 0
- --------------------------------------------------------------------------------
(CUSIP number)
NEIL G. CAWSEY; FOREST CITY ENTERPRISES, 1160 TERMINAL TOWER, 50 PUBLIC SQUARE,
CLEVELAND, OHIO 44113; (216) 416-3277
- --------------------------------------------------------------------------------
(Name, address and telephone number of person
authorized to receive notices and communications)
MAY 15, 1998
- --------------------------------------------------------------------------------
(Date of event which requires filing of this statement)
If the filing person has previously filed a statement on Schedule 13G
to report the acquisition which is the subject of this Schedule 13D, and is
filing this schedule because of Rule 13d-1 (b)(3) or (4), check the following
box [ ].
Check the following box if a fee is being paid with the statement. [ ]
(A fee is not required only if the reporting person: (1) has a previous
statement on file reporting beneficial ownership of more than five percent of
the class of securities described in Item 1; and (2) has filed no amendment
subsequent thereto reporting beneficial ownership of five percent or less of
such class.) (See Rule 13d-7.)
Note. Six copies of this statement, including all exhibits, should be
filed with the Commission. See Rule 13d-1 (a) for other parties to whom copies
are to be sent.
(Continued on following pages)
(Page 1 of 6 Pages)
- ------------------
1 The remainder of this cover page shall be filled out for a
reporting person's initial filing on this form with respect to the subject class
of securities, and for any subsequent amendment containing information which
would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not
be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange
Act of 1934 or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
2
SCHEDULE 13D
- --------------------------------------------------------------------------------
- --------------------------- -----------------------------
CUSIP No. 872342 10 0 13D Page 2 of 6 Pages
---------------- ------- ------
- --------------------------- -----------------------------
- --------- -------------------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSONS
S.S. OR I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS
FOREST CITY 38 SIDNEY STREET, INC.
- --------- -------------------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) [ ]
(b) [ ]
- --------- -------------------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- --------- -------------------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS
OO*
- --------- -------------------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEM 2(d) or 2(e)
[ ]
- --------- -------------------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
OHIO
- --------- -------------------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF 1,433,750**
SHARES -------------------------------------------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY N/A
EACH -------------------------------------------------------------------------------------------------
REPORTING 9 SOLE DISPOSITIVE POWER
PERSON WITH 1,433,750**
-------------------------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
N/A
- --------- -------------------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
1,433,750**
- --------- -------------------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES [ ]
- --------- -------------------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
5.10%
- --------- -------------------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON
CO
- --------- -------------------------------------------------------------------------------------------------------------------
3
* The consideration used by Forest City 38 Sidney Street, Inc. (hereafter,
"Forest City") in acquiring the Common Shares of T Cell Sciences, Inc.
(hereafter, "T Cell") involved Forest City's execution of a Settlement
Agreement, dated November 14, 1997, between Forest City and T Cell (hereafter,
the "Settlement Agreement"), releasing and discharging alleged T Cell
liabilities arising out of Forest City claims under certain leases between
Forest City and T Cell.
** Initially, the Settlement Agreement allowed Forest City limited control
over 132,500 Common Shares, issued in two equal 66,250 Common Shares
certificates and each as separate collateral securing certain T Cell installment
payments required under the Settlement Agreement. The Settlement Agreement
restricted Forest City's sole dispositive power with regard to these two 66,250
Common Shares certificates, ultimately subjecting both of them to return to T
Cell upon T Cell's provision of cash collateral in a form reasonably
satisfactory to Forest City to secure further payment obligations. Forest City
otherwise obtained the sole voting power regarding these 132,500 Common Shares
under the Settlement Agreement. On May 5, 1998, T-Cell met its cash collateral
obligations with regard to 66,250 Common Shares and Forest City returned one
66,250 Common Shares certificate to T-Cell to reflect such satisfaction. Forest
City obtained sole dispositive power regarding the other 66,250 Common Shares on
May 15, 1998, when T Cell's cash collateral provision alternative expired
pursuant to the Settlement Agreement.
4
SCHEDULE 13D
Item 1. Security and Issuer.
(a) Common Shares, par value $.001
(b) T Cell Sciences, Inc. (hereafter, "T Cell")
119 Fourth Avenue
Needham, Massachusetts
Item 2. Identity and Background.
Name: Forest City 38 Sidney Street, Inc.
(hereafter, "Forest City")
State of organization: Ohio
Principal business: Owner and lessor of commercial properties
Principal business address: 1100 Terminal Tower, Cleveland,
Ohio, 44113
Principal office address: 1100 Terminal Tower, Cleveland,
Ohio, 44113
(d) Not Applicable
(e) Not Applicable
Item 3. Source and Amount of Funds or Other Consideration.
The Common Shares of T Cell were acquired by Forest City pursuant to a
Settlement Agreement dated November 14, 1997, (hereafter, the
"Settlement Agreement") between Forest City and T Cell in consideration
of Forest City's release and discharge of T Cell's alleged liability
arising out of claims asserted under certain leases.
Item 4. Purpose of the transaction.
As stated in Item 3 above, the purpose of Forest City's acquiring the T
Cell Common Shares was to satisfy the Settlement Agreement executed
between T Cell and Forest City.
Item 5. Interest in Securities of the Issuer.
(a) The aggregate number of Common Shares beneficially
owned by Forest City is 1,433,750, which comprises
approximately 5.10% of the outstanding T Cell Common
Shares. The number of aggregate Common Shares
reported includes 66,250 Common Shares initially
issued to Forest City by T Cell as collateral
securing certain T Cell installment payments required
under the Settlement Agreement. The Settlement
Agreement restricted the sole dispositive power of
Forest City regarding the 66,250 Common Shares and
subjected the 66,250 Common Shares to
5
return to the issuer upon T Cell's provision of cash
collateral in a form reasonably satisfactory to
Forest City to secure further payment obligations. On
May 15, 1998 Forest City obtained sole dispositive
power regarding these 66,250 Common Shares.
(b) 1,433,750 Common Shares, with sole power to direct
the vote and disposition.
(c) Not Applicable.
(d) Not Applicable.
(e) Not Applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships with
Respect to Securities of the Issuer.
None.
Item 7. Material to Be Filed as Exhibits.
None.
6
SIGNATURE
After reasonable inquiry and to the best of my knowledge and
belief, I certify that the information set forth in this statement is true,
complete and correct.
July 15, 1998 FOREST CITY 38 SIDNEY STREET, INC.
/s/ Thomas G. Smith
------------------------------------------
By: Thomas G. Smith
Its: Secretary